proxyvotesnow.com

Home › Asset managers › ProShares › 2024-2025 › Against the board

ProShares 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

2,842 proposals.

ProShares, 2024-2025 proxy season. Who put a proposal on the ballot is taken from its N-PX category; see the method note on the overview page.
CompanyMeetingProposalCategory On the ballot fromProShares votedFunds
Rush Enterprises, Inc. 2025-05-20 Election of Directors: Troy A. Clarke Director Elections Board ABSTAIN 13
SL Green Realty Corp. 2025-06-03 Election of Directors: John H. Alschuler Director Elections Board AGAINST 13
SL Green Realty Corp. 2025-06-03 Election of Directors: Lauren B. Dillard Director Elections Board AGAINST 13
SL Green Realty Corp. 2025-06-03 To approve our Sixth Amended and Restated 2005 Stock Option and Incentive Plan. Compensation Board AGAINST 13
SL Green Realty Corp. 2025-06-03 To approve, on a non-binding advisory basis, our executive compensation. Say-on-Pay Board AGAINST 13
Seacoast Banking Corporation of Florida 2025-05-19 Advisory (Non-binding) Vote on Compensation of Named Executive Officers Say-on-Pay Board AGAINST 13
Simulations Plus, Inc. 2025-02-13 Election of Directors: Dr. Walter S. Woltosz Director Elections Board ABSTAIN 13
Sprinklr, Inc. 2025-06-12 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 13
Sprinklr, Inc. 2025-06-12 To elect three Class I directors, each to hold office until our Annual Meeting of Stockholders in 2028: Jan R. Hauser Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 An advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board AGAINST 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Daniel Hume Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Kenneth Hoberman Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Laurence Charney Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Michael S. Weiss Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Sagar Lonial, MD Director Elections Board ABSTAIN 13
TG Therapeutics, Inc. 2025-06-12 Election of Directors: Yann Echelard Director Elections Board ABSTAIN 13
Vicor Corporation 2025-06-20 To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Samuel J. Anderson Director Elections Board ABSTAIN 13
Whitestone REIT 2025-05-15 To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation Board AGAINST 13
Arbor Realty Trust, Inc. 2025-05-21 Advisory vote to approve the compensation of Arbor Realty Trust, Inc.'s named executive officers as disclosed in the proxy statement. Say-on-Pay Board AGAINST 12
Atlas Energy Solutions Inc. 2025-05-08 Election to the Company's Board of Directors of the three Class II directors set forth in the accompanying proxy statement, each of whom will hold office until the 2028 Annual Meeting of Stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal: A. Lance Langford Director Elections Board ABSTAIN 12
BGC Group, Inc. 2024-09-16 Approval, on an advisory basis, of executive compensation. Say-on-Pay Board AGAINST 12
BGC Group, Inc. 2024-09-16 Election of Directors: Arthur U. Mbanefo Director Elections Board ABSTAIN 12
BGC Group, Inc. 2024-09-16 Election of Directors: David P. Richards Director Elections Board ABSTAIN 12
BGC Group, Inc. 2024-09-16 Election of Directors: Howard W. Lutnick Director Elections Board ABSTAIN 12
BGC Group, Inc. 2024-09-16 Election of Directors: Linda A. Bell Director Elections Board ABSTAIN 12
BGC Group, Inc. 2024-09-16 Election of Directors: William D. Addas Director Elections Board ABSTAIN 12
BioLife Solutions, Inc. 2024-08-01 Election of Directors: Joydeep Goswami Director Elections Board ABSTAIN 12
BioLife Solutions, Inc. 2024-08-01 Election of Directors: Rachel Ellingson Director Elections Board ABSTAIN 12
Cactus, Inc. 2025-05-13 To approve the amendment of the Company's Long-Term Incentive Plan, as amended and restated effective May 16, 2023, to increase the number of shares of the Company's Class A common stock reserved for issuance under such plan from 5,500,000 to 8,500,000. Compensation Board AGAINST 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Brendan P. Dougher Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Brooks M. Pennington III Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Christopher T. Metz Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Courtnee Chun Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: John R. Ranelli Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Lisa Coleman Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: M. Beth Springer Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: Nicholas Lahanas Director Elections Board ABSTAIN 12
Central Garden & Pet Company 2025-02-12 Election of Directors: William E. Brown Director Elections Board ABSTAIN 12
DigitalOcean Holdings, Inc. 2025-06-09 Election of Class I Director: Padmanabhan Srinivasan Director Elections Board ABSTAIN 12
Hilltop Holdings, Inc. 2024-07-25 Election of Directors: W. Robert Nichols, III Director Elections Board ABSTAIN 12
Innovex International, Inc. 2025-05-14 To adopt the Company's 2025 Long-Term Incentive Plan. Compensation Board AGAINST 12
John B. Sanfilippo & Son, Inc. 2024-10-30 Election of Directors: Ellen C. Taaffe Director Elections Board ABSTAIN 12
John B. Sanfilippo & Son, Inc. 2024-10-30 Election of Directors: Mercedes Romero Director Elections Board ABSTAIN 12
John B. Sanfilippo & Son, Inc. 2024-10-30 Election of Directors: Pamela Forbes Lieberman Director Elections Board ABSTAIN 12
Lattice Semiconductor Corporation 2025-05-02 To approve on a non-binding, advisory basis, our Named Executive Officers' compensation. Say-on-Pay Board AGAINST 12
Matthews International Corporation 2025-02-20 To elect three (3) directors for a term of three (3) years. COMPANY NOMINEES OPPOSED BY BARINGTON: Terry L. Dunlap Director Elections Board ABSTAIN 12
National Beverage Corp. 2024-10-04 Election of Directors: Samuel C. Hathorn, Jr. Director Elections Board ABSTAIN 12
NexPoint Residential Trust, Inc. 2025-05-20 To elect seven directors to serve until the 2026 annual meeting of stockholders: James Dondero Director Elections Board ABSTAIN 12
PDD Holdings Inc. 2024-12-20 As an ordinary resolution: THAT Mr. Haifeng Lin be re-elected as a director of the Company. Director Elections Board AGAINST 12
PDD Holdings Inc. 2024-12-20 As an ordinary resolution: THAT Mr. Jiazhen Zhao be re-elected as a director of the Company. Director Elections Board AGAINST 12
PDD Holdings Inc. 2024-12-20 As an ordinary resolution: THAT Mr. Lei Chen be re-elected as a director of the Company. Director Elections Board AGAINST 12
Phibro Animal Health Corporation 2024-11-05 Election of Class II Directors: Carol A. Wrenn Director Elections Board ABSTAIN 12
Phibro Animal Health Corporation 2024-11-05 Election of Class II Directors: Mary Lou Malanoski Director Elections Board ABSTAIN 12
Retail Opportunity Investments Corp. 2025-02-07 Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our principal executive officer, principal financial officer, and the three other most highly compensated executive officers that is based on or otherwise related to the company merger as more fully described in the Proxy Statement, Say-on-Pay Board AGAINST 12
Roivant Sciences Ltd. 2024-09-10 To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan Oren Director Elections Board ABSTAIN 12
StepStone Group Inc. 2024-09-10 To approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of shares of the Company's Class A common stock pursuant to the terms of the Option Agreement, dated November 2, 2022, between the Company and the other parties thereto. Capital Structure Board AGAINST 12
Sunrun Inc. 2025-06-11 Advisory proposal of the compensation of our named executive officers ("Say-on-Pay"). Say-on-Pay Board AGAINST 12
Ultra Clean Holdings, Inc. 2025-05-21 Approval, by an advisory vote, of the compensation of Ultra Clean Holdings, Inc.'s named executive officers for fiscal 2024 as disclosed in our proxy statement for the 2025 Annual Meeting of Stockholders. Say-on-Pay Board AGAINST 12
Ultra Clean Holdings, Inc. 2025-05-21 Election of Directors: David T. ibnAle Director Elections Board AGAINST 12
Ultra Clean Holdings, Inc. 2025-05-21 Election of Directors: Ernest E. Maddock Director Elections Board AGAINST 12
Ultra Clean Holdings, Inc. 2025-05-21 Election of Directors: Thomas T. Edman Director Elections Board AGAINST 12
Vector Group Ltd. 2024-08-20 Advisory vote on executive compensation (the "say on pay vote"): Say-on-Pay Board AGAINST 12
Worthington Enterprises, Inc. 2024-09-24 Approve the Worthington Enterprises, Inc. 2024 Long-Term Incentive Plan. Compensation Board AGAINST 12
3D Systems Corporation 2024-08-30 The approval of the amendment and restatement of the 2015 Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 4,000,000 shares; and Compensation Board AGAINST 11
3D Systems Corporation 2024-08-30 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections Board AGAINST 11
3D Systems Corporation 2024-08-30 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections Board AGAINST 11
3D Systems Corporation 2024-08-30 The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan Director Elections Board AGAINST 11
89bio, Inc. 2025-05-28 Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. Director Elections Board ABSTAIN 11
ARS Pharmaceuticals, Inc. 2025-06-25 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal Director Elections Board ABSTAIN 11
AdaptHealth Corp. 2025-06-18 Election of Directors - To elect the six director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Terence Connors Director Elections Board ABSTAIN 11
Agios Pharmaceuticals, Inc. 2025-06-18 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares. Compensation Board AGAINST 11
Akero Therapeutics, Inc. 2025-06-03 To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Judy Chou, Ph.D. Director Elections Board ABSTAIN 11
Allegiant Travel Company 2025-06-26 Approval of an amendment to the Allegiant Travel Company 2022 Long-Term Incentive Plan. Compensation Board AGAINST 11
Amneal Pharmaceuticals, Inc. 2025-05-06 Election of Directors: Paul Meister Director Elections Board AGAINST 11
AnaptysBio, Inc. 2025-06-17 To approve an amendment to our 2017 Equity Incentive Plan. Compensation Board AGAINST 11
AnaptysBio, Inc. 2025-06-17 To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay Board AGAINST 11
AnaptysBio, Inc. 2025-06-17 To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D. Director Elections Board ABSTAIN 11
Anavex Life Sciences Corp. 2025-06-10 To approve an amendment to the Company's 2022 Omnibus Incentive Plan. Compensation Board AGAINST 11
Apogee Therapeutics, Inc. 2025-06-17 Election of Class II Directors for terms expiring in 2028: Lisa Bollinger, M.D. Director Elections Board ABSTAIN 11
Apogee Therapeutics, Inc. 2025-06-17 Election of Class II Directors for terms expiring in 2028: Nimish Shah Director Elections Board ABSTAIN 11
Arcutis Biotherapeutics, Inc. 2025-06-12 Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Bhaskar Chaudhuri, Ph.D. Director Elections Board ABSTAIN 11
Arcutis Biotherapeutics, Inc. 2025-06-12 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 11
Ardelyx, Inc. 2025-06-18 To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan; and Compensation Board AGAINST 11
Ardelyx, Inc. 2025-06-18 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: David Mott Director Elections Board ABSTAIN 11
ArriVent BioPharma, Inc. 2025-06-18 Election of Directors: Kristine Peterson Director Elections Board ABSTAIN 11
ArriVent BioPharma, Inc. 2025-06-18 Election of Directors: Zhengbin (Bing) Yao, Ph.D. Director Elections Board ABSTAIN 11
Arvinas, Inc. 2025-06-25 Election of three Class I directors: John Houston, Ph.D. Director Elections Board ABSTAIN 11
Arvinas, Inc. 2025-06-25 Election of three Class I directors: Laurie Smaldone Alsup, M.D. Director Elections Board ABSTAIN 11
Arvinas, Inc. 2025-06-25 Election of three Class I directors: Linda Bain Director Elections Board ABSTAIN 11
Avanos Medical, Inc. 2025-04-24 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares. Compensation Board AGAINST 11
Avidity Biosciences, Inc. 2025-06-10 To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and Say-on-Pay Board AGAINST 11
Axsome Therapeutics, Inc. 2025-06-06 Election of Director: Roger Jeffs, Ph.D. Director Elections Board ABSTAIN 11
Axsome Therapeutics, Inc. 2025-06-06 To approve the Company's 2025 Long-Term Incentive Plan. Compensation Board AGAINST 11
BioCryst Pharmaceuticals, Inc. 2025-06-12 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation Board AGAINST 11
Blueprint Medicines Corporation 2025-06-18 Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Jeffrey Albers Director Elections Board ABSTAIN 11
Brandywine Realty Trust 2025-05-21 Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation Board AGAINST 11
BridgeBio Pharma, Inc. 2025-06-20 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation Board AGAINST 11
BridgeBio Pharma, Inc. 2025-06-20 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 11
Brookline Bancorp, Inc. 2025-05-21 A proposal to approve, on a non-binding advisory basis, the compensation that may become payable to the named executive officers of Brookline in connection with the Mergers (the "Brookline Merger-Related Compensation Proposal"). Say-on-Pay Board AGAINST 11
CG Oncology, Inc. 2025-06-05 To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Arthur Kuan Director Elections Board ABSTAIN 11

← Previous Page 4 of 29 Next →

← Back to ProShares 2024-2025 overview

Built 2026-10-04 from SEC Form N-PX filings.